{
  "updatedAt": "2026-02-04T04:55:14.802Z",
  "surveillance": {
    "lastRun": "2026-02-04T04:54:48.050Z",
    "reasoning": null
  },
  "literature": {
    "lastRun": "2026-02-04T04:55:03.288Z",
    "reasoning": "The agent reasons over ingested literature for each autonomous-agent topic (Clinical-Adjacent and Research & Discovery). Data from sources; reasoning from patterns and inferred gaps.\n\n- **Early Detection of Disease Across Species** — 10 item(s). **Reasoning:** Prioritize validation of preclinical signals and early biomarkers for clinical use.\n- **Decoding Animal Pain and Distress** — 5 item(s). **Reasoning:** Aggregate behavior, physiology, and biomarker studies to improve recognition in stoic species.\n- **Preclinical Disease States** — 5 item(s). **Reasoning:** Prioritize validation of preclinical signals and early biomarkers for clinical use.\n- **Unexplained Recovery and Resilience** — 5 item(s). **Reasoning:** Identify protective factors and care patterns from outlier recovery cases.\n- **Microbiome–Behavior–Health Coupling** — 5 item(s). **Reasoning:** Map microbiome–behavior–health links for interventions and diet trials.\n- **Biological Timing and Treatment Response** — 1 item(s). **Reasoning:** Use timing data to optimize anesthesia, vaccination, and treatment windows.\n- **Latent Protective Mechanisms** — 5 item(s). **Reasoning:** Explore uncharacterized signals and anomalies for new biology or biomarkers.\n- **Hidden Costs of Normal Physiology** — 5 item(s). **Reasoning:** Quantify cumulative cost of stress and inflammation for prevention.\n- **Genetic Intervention and Biological Integrity** — 5 item(s). **Reasoning:** Integrate gene editing and early-life effects into health and welfare assessment.\n- **Unexpected Correlations and Anomalies** — 5 item(s). **Reasoning:** Explore uncharacterized signals and anomalies for new biology or biomarkers."
  },
  "synthesis": {
    "lastRun": "2026-02-04T04:55:14.802Z",
    "reasoning": "### From surveillance\n\n**Conditions to watch (travel / zoonotic):**\n- A Strain of Multidrug-Resistant &lt;em&gt;Salmonella&lt;/em&gt; Newport — consider travel alerts or client advice.\n- Animal disease alerts — consider travel alerts or client advice.\n- Chikungunya — consider travel alerts or client advice.\n- Clade II Monkeypox — consider travel alerts or client advice.\n- Diphtheria — consider travel alerts or client advice.\n- East African Sleeping Sickness — consider travel alerts or client advice.\n- Extensively Drug-Resistant Typhoid Fever — consider travel alerts or client advice.\n- Global Dengue — consider travel alerts or client advice.\n- Global Measles — consider travel alerts or client advice.\n- Global Polio — consider travel alerts or client advice.\n\n**Opportunity:** Review new CDC notices and surface alerts for vets and one-health partners.\n\n### From literature\n\n- **Partnerships:** New one-health and cancer papers suggest collaboration and comparative oncology opportunities.\n- **Research gaps:** Case reports and literature themes point to teaching material and emerging patterns.\n- **Opportunity:** Summarize \"new this period\" for researchers and clinics.\n\n### Reasoning by autonomous-agent topic\n\nThe literature reviewer reasons over ingested data for each autonomous-agent topic (Clinical-Adjacent and Research & Discovery). Inferred opportunities:\n\nThe agent reasons over ingested literature for each autonomous-agent topic (Clinical-Adjacent and Research & Discovery). Data from sources; reasoning from patterns and inferred gaps.\n- **Early Detection of Disease Across Species** — 10 item(s). **Reasoning:** Prioritize validation of preclinical signals and early biomarkers for clinical use.\n- **Decoding Animal Pain and Distress** — 5 item(s). **Reasoning:** Aggregate behavior, physiology, and biomarker studies to improve recognition in stoic species.\n- **Preclinical Disease States** — 5 item(s). **Reasoning:** Prioritize validation of preclinical signals and early biomarkers for clinical use.\n- **Unexplained Recovery and Resilience** — 5 item(s). **Reasoning:** Identify protective factors and care patterns from outlier recovery cases.\n- **Microbiome–Behavior–Health Coupling** — 5 item(s). **Reasoning:** Map microbiome–behavior–health links for interventions and diet trials.\n- **Biological Timing and Treatment Response** — 1 item(s). **Reasoning:** Use timing data to optimize anesthesia, vaccination, and treatment windows.\n- **Latent Protective Mechanisms** — 5 item(s). **Reasoning:** Explore uncharacterized signals and anomalies for new biology or biomarkers.\n- **Hidden Costs of Normal Physiology** — 5 item(s). **Reasoning:** Quantify cumulative cost of stress and inflammation for prevention.\n- **Genetic Intervention and Biological Integrity** — 5 item(s). **Reasoning:** Integrate gene editing and early-life effects into health and welfare assessment.\n- **Unexpected Correlations and Anomalies** — 5 item(s). **Reasoning:** Explore uncharacterized signals and anomalies for new biology or biomarkers.\n\n\n### From system insights\n\n- Surveillance: review new CDC travel notices for alerts.\n- Literature: review new papers for partnerships and gaps.\n- Cancer / case data / imaging: use for teaching, collaboration, or model development.\n\n### For veterinary medicine (clinic use)\n\n- **In the clinic:** Use surveillance for travel/zoonotic client advice; clinical + case_data for differentials, protocols, and CE; vet_practice (AAHA, AVMA, VIN, Merck) for guidelines and client handouts.\n- **Opportunities:** New clinical/small animal/equine papers → protocols or rounds; new case reports → teaching or client materials; vet_practice links → client resources.\n\n---\n\n*Agents run on the same machine (or VM) after each ingest. Add more reviewers by adding scripts and having the synthesizer read them.*"
  }
}